Price (delayed)
$1.48
Market cap
$65.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.69
Enterprise value
-$27.57M
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in ...
Highlights
The company's debt fell by 19% YoY and by 7% QoQ
The net income has contracted by 21% YoY and by 9% from the previous quarter
EPIX's quick ratio is down by 19% year-on-year and by 15% since the previous quarter
Key stats
What are the main financial stats of EPIX
MarketValuationsEarnings
Shares outstanding
44.39M
Market cap
$65.7M
Enterprise value
-$27.57M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.55
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$36.51M
Net income
-$31.11M
EBIT
-$31.11M
EBITDA
-$31.02M
Free cash flow
-$22.4M
Per shareBalance sheetLiquidity
EPS
-$0.69
EPS diluted
-$0.69
Free cash flow per share
-$0.5
Book value per share
$2.68
Revenue per share
$0
TBVPS
$2.76
Total assets
$122.63M
Total liabilities
$3.87M
Debt
$305,043
Equity
$118.77M
Working capital
$118.42M
Debt to equity
0
Current ratio
33.12
Quick ratio
32.81
Net debt/EBITDA
3.01
MarginsEfficiencyDividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-23.9%
Return on equity
-24.6%
Return on invested capital
-94.1%
Return on capital employed
-26.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EPIX stock price
How has the Essa Pharma stock price performed over time
Intraday
-6.33%
1 week
-5.13%
1 month
-10.84%
1 year
-81.86%
YTD
-17.32%
QTD
-6.33%
Financial performance
How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$36.51M
Net income
-$31.11M
Gross margin
N/A
Net margin
N/A
EPIX financials
The net income has contracted by 21% YoY and by 9% from the previous quarter
EPIX's operating income is down by 15% year-on-year and by 6% since the previous quarter
Growth
What is Essa Pharma's growth rate over time
EPIX growth chart
Valuation
What is Essa Pharma stock price valuation
P/E
N/A
P/B
0.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Price to earnings (P/E)
The EPS has decreased by 17% YoY and by 8% QoQ
Price to book (P/B)
The stock's price to book (P/B) is 75% less than its 5-year quarterly average of 2.2 and 71% less than its last 4 quarters average of 1.9
EPIX's equity is down by 16% year-on-year and by 4.7% since the previous quarter
Price to sales (P/S)
Efficiency
How efficient is Essa Pharma business performance
EPIX's return on invested capital has dropped by 75% since the previous quarter
EPIX's return on assets is down by 41% year-on-year and by 14% since the previous quarter
EPIX's ROE is down by 41% YoY and by 14% from the previous quarter
Dividends
What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EPIX.
Financial health
How did Essa Pharma financials performed over time
Assets vs liabilities
EPIX's quick ratio is down by 19% year-on-year and by 15% since the previous quarter
The company's current ratio fell by 19% YoY and by 14% QoQ
Debt vs equity
The company's debt is 100% lower than its equity
The company's debt fell by 19% YoY and by 7% QoQ
EPIX's equity is down by 16% year-on-year and by 4.7% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.